Citigroup »

Palvella Therapeutics Inc Ne shares owned by Citigroup

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $312k 2.5k 124.65
2025-03-31 $63k 2.2k 27.99
2024-12-31 $13k 1.1k 12.00

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
First Light Asset Management
BVF
Frazier Life Sciences Management
BlackRock
Jennison Associates
Vanguard Group
Vanguard Capital Management
Federated Investors
State Street Corporation
Summit Partners Public Asset Management
Woodline Partners
Alliancebernstein
FMR
MPM Oncology Impact Management

View all funds holding Palvella Therapeutics Inc Ne